Abstract
Each year, millions of patients visit physicians seeking relief from tensions, fears, worries, anxieties, and depression. Most physicians have found psychopharmacological agents, prescribed within the context of supportive, ventilating, or nonexploratory, as well as dynamic and insight-oriented psychotherapy, most useful for alleviating these disturbing emotions. Psychopharmacological agents do not, of course, represent a panacea for all neurotic ills. They do not, for example, directly affect the psychodynamic and environmental factors responsible for emotional problems; they do not directly affect the characterological or personality side of the patient (Joyce, 1971). By relieving the symptoms of anxiety, tension, and depression, however, they often render a patient less miserable and able to cope with intrapsychic and extrapsychic stress more appropriately.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bailey, D. W., and Fenichel, G. M., 1968, The treatment of prolonged seizure activity with intravenous diazepam, J. Pediatr.73:923–927.
Balter, M. B., and Levine, J., 1969, The nature and extent of psychotropic drug usage in the United States, Psychopharmacol. Bull.5:3–13.
Benson, W. H., 1971, Comparative evaluation of diazepam (Valium) and phenobarbital for the relief of anxiety-related symptoms in patients hospitalized for acute myocardial infarction, J. Med. Assoc. Ga.60:276–278.
Berger, F. M., 1963, The similarities and differences between meprobamate and barbiturates, Clin. Pharmacol. Ther.4:209–231.
Berger, F. M., 1967, The role of drugs in suicide, in: Symposium on Suicide (L. Yochelson, ed.), pp. 117–132, George Washington University, Washington, D.C.
Blackwell, B., 1973, Psychotropic drugs in use today: The role of diazepam in medical practice, J. Am. Med. Assoc.225:1637–1641.
Byck, R., 1975, Drugs and the treatment of psychiatric disorders, in: The Pharmacological Basis of Therapeutics, 5th ed. (L. S. Goodman and A. Gilman, eds.), p. 188, Macmillan, New York.
Carter, S., and Gold, A. P., 1969, The critically ill child: Management of status epilepticus, Pediatrics44:732–733.
Cazort, R. J., 1964, Role of relaxants in the treatment of traumatic musculoskeletal disorders: A double-blind study of three agents, Curr. Ther. Res.6:454–458.
Cooper, A. J., Magnus, R. V., Rose, M., Phanjoo, A., Lancaster, N. P., Pollard, P., and Knowlson, P., 1973, Controlled trial of dipotassium chlorazepate (‘Tranxene’) in anxiety, Br. J. Psychiatry123:475–476.
Covi, L., Lipman, R. S., Pattison, J. H., Derogatis, L. R., and Uhlenhuth, E. H., 1973, Length of treatment with anxiolytic sedatives and response to their sudden withdrawal, Acta Psychiatr. Scand.49:51–64.
Derogatis, L. R., Lipman, R. S., Rickels, K., Uhlenhuth, E. H., and Covi, L., 1974, The Hopkins Symptom Checklist (HSCL): A measure of primary symptom dimensions, in: Psychological Measurements in Psychopharmacology, Modern Problems in Pharmacopsychiatry, Vol. 7 (P. Pichot, ed.), pp. 79–110, Karger, Basel.
DiMascio, A., Shader, R. I., and Harmatz, J., 1969, Psychotropic drugs and induced hostility, Psychosomatics10:46–47.
Dunbar, R. W., Boettner, R. B., Haley, J. V., Hall, V. E., and Morrow, D. H., 1971, The effect of diazepam on the antiarrhythmic response to lidocaine, Anesth. Analg.50:685–692.
Goldberg, H. L., and Finnerty, R. J., 1977, A double-blind study of prazepam vs. placebo in single doses in the treatment of anxiety. Compr. Psychiatry18:147–156.
Greenblatt, D. J., and Shader, R. L, 1974a, The treatment of alcoholism and other drug-dependent states, in: Benzodiazepines in Clinical Practice (D. J. Greenblatt and R. I. Shader, eds.), pp. 217–229, Raven Press, New York.
Greenblatt, D. J., and Shader, R. I., 1974, Benzodiazepines in Clinical Practice, Raven Press, New York.
Greenblatt, D. J., Shader, R. I., and Koch-Weser, J., 1975, Flurazepam hydrochloride, Clin. Pharmacol. Ther.17:1–14.
Hackett, T. P., and Cassem, N. H., 1972, Reduction of anxiety in the coronary-care unit: A controlled double-blind comparison of chlordiazepoxide and amobarbital, Curr. Ther. Res.14:649–656.
Hamilton, M., 1959, The assessment of anxiety states by rating, Br. J. Med. Psychol.32:50–55.
Hesbacher, P. T., Rickels, K., Gordon, P. E., Gray, B., Meckelnburg, R., Weise, C. C., and Vandervort, W. J., 1970a, Setting, patient, and doctor effects on drug response in neurotic patients: I. Differential attrition, dosage deviation and side reaction responses to treatment,Psychopharmacologia(Berlin)18:180–208.
Hesbacher, P. T., Rickels, K., Hutchison, J., Raab, E., Sablosky, L., Whalen, E. M., and Phillips, F. J., 1970b, Setting, patient, and doctor effects on drug response in neurotic patients: II. Differential improvement, Psychopharmacologia (Berlin)18:209–226.
Hesbacher, P. T., Rickels, K., Rial, W. Y., Segal, A., and Zamostien, B. B., 1976, Psychotropic drug prescription in family practice Compr. Psychiatry17:607–615.
Hollister, L. E., 1966, Overdoses of psychotherapeutic drugs, Clin. Pharmacol. Ther.7:142–146.
Hollister, L. E., and Glazener, F. S., 1960, Withdrawal reactions from meprobamate, alone and combined with promazine: A controlled study, Psychopharmacologia1:336–341.
Hollister, L. E., Motzenbecker, F. P., and Degan, R. O., 1961, Withdrawal reactions from chlordiazepoxide (“Librium”), Psychopharmacologia2:63–68.
Hollister, L. E., Overall, J. E., Shelton, J., Pennington, V., Kimbell, I., and Johnson, M., 1967, Drug therapy of depression, Arch. Gen. Psychiatry17:486–493.
Hollister, L. E., Overall, J. E., Pokorny, A. D., and Shelton, J., 1971, Acetophenazine and diazepam in anxious depressions, Arch. Gen. Psychiatry24:273–278.
Jenner, F. A., and Parkin, D., 1961, A large overdose of chlordiazepoxide, Lancet2:322–323.
Joyce, C. R. B., 1971, Can drugs affect personality? in: Ciba Foundation Symposium on Personality and Science (I. T. Ramsey and R. Porter, eds.), pp. 65–72, Churchill Livingstone, London.
Kaim, S. C., Klett, C. J., and Rothfeld, B., 1969, Treatment of the acute alcohol withdrawal state, a comparison of four drugs, Am. J. Psychiatry125:1640–1646.
Kielholz, P., Goldberg, L., Obersteg, J., Poeldinger, W., Ramseyer, A., and Schmid, P., 1967, Circulation routière, tranquillisants et alcohol, Hyg. Ment.2:39–60.
Kisson, M. D., 1965, Management of psychomotor agitation in acute alcoholism. A double-blind study using chlordiazepoxide, Dis. Nerv. Syst.26:364–368.
Klein, D. F., 1964, Delineation of two drug-responsive anxiety syndromes, Psychopharmacologia5:397–408.
Klerman, G. L., 1974, Psychotropic drugs as therapeutic agents, Hastings Cent. Stud.2(1):81–93.
Klerman, G. L., DiMascio, A., Weissman, M., Prusoff, B., and Paykel, E. S., 1974, Treatment of depression by drugs and psychotherapy, Am. J. Psychiatry131:186–191.
Lader, M., 1974, The peripheral and central role of the catecholamines in the mechanisms of anxiety, Int. Pharmacopsychiatry9:125–137.
Linnoila, M., and Häkkinen, S., 1974, Effects of diazepam and codeine, alone and in combination with alcohol, on simulated driving, Clin. Pharmacol. Ther.15:368–373.
Lipman, R. S., Covi, L., Rickels, K., Uhlenhuth, E. H., and Lazar, R., 1968, Selected measures of change in outpatient drug evaluation, in: Psychopharmacology: A Review of Progress, 1957–1967 (D. H. Efron, J. O. Cole, J. Levine, and J. R. Wittenborn, eds.), pp. 249–254, Public Health Service Publication No. 1836, Washington, D.C.
Lipman, R. S., Uhlenhuth, E. H., Rickels, K., and Covi, L., 1969, Medication attitudes and drug response, Dis. Nerv. Syst.30:454–459.
McMillin, W. P., 1973, Oxprenolol in anxiety, Lancet1:1193.
Overall, J. E., Hollister, L. E., Meyer, F., Kimbell, I., and Shelton, J., 1964, Imipramine and thioridazine in depressed and schizophrenic patients, J. Am. Med. Assoc.189:605–608.
Ramsay, I., Greer, S., et al. Bagley, C., 1973, Propranolol in neurotic and thyrotoxic anxiety, Br. J. Psychiatry122:555–560.
Rickels, K., 1968, Antineurotic agents: Specific and non-specific effects, in: Psychopharmacol-ogy: A Review of Progress, 1957–1967 (D. H. Efron, J. O. Cole, J. Levine, and J. R. Wittenborn, eds.), pp. 231–247, Public Health Service Publication No. 1836, Washington, D.C.
Rickels, K., and Downing, R. W., 1974, Chlordiazepoxide and hostility in anxious outpatients, Am. J. Psychiatry131:442–444.
Rickels, K., and Hesbacher, P. T., 1973, Over-the-counter daytime sedatives: A controlled study, J. Am. Med. Assoc.223:29–33.
Rickels, K., and Howard, K., 1970, The physician questionnaire: A useful tool in psychiatric drug research, Psychopharmacologia17:338–344.
Rickels, K., Lipman, R. S., and Raab, E., 1966, Previous medication, duration of illness and placebo response, J. Nerv. Ment. Dis.142:548–554.
Rickels, K., Raab, E., DeSilverio, R., and Etemad, B., 1967, Drug treatment in depression: Antidepressant or tranquilizer? J. Am. Med. Assoc.201:675–681.
Rickels, K., Sablosky, H., Silverman, H., Case, W. G., Rial, W., Mirman, M., and Gottlieb, S., 1977, Prazepam in anxiety: A controlled clinical trial, Compr. Psychiatry18:239–249.
Rickels, K., Garcia, C.-R., and Fisher, E., 1971a, A measure of emotional distress in private gynecologic practice, Obstet. Gynecol.38:139–146.
Rickels, K., Lipman, R. S., Park, L. C., Covi, L., Uhlenhuth, E. H., and Mock, J. E., 1971b, Drug, doctor warmth, and clinic setting in the symptomatic response to minor tranquilizers, Psychopharmacologia20:128–152.
Rickels, K., Chung, H. R., Feldman, H. S., Gordon, P. E., Kelly, E. A., and Weise, C. C., 1973, Amitriptyline, diazepam, and phenobarbital sodium in depressed outpatients, J. Nerv. Ment. Dis.157:442–451.
Rickels, K., Pereira-Ogan, J. A., Case, W. G., Csanalosi, I., Mirman, M. J., Nathanson, J. E., and Parish, L. C., 1974, Chlormezanone in anxiety: A drug rediscovered? Am. J. Psychiatry131:592–595.
Rickels, K., Gingrich, R. L., Morris, R. J., Rosenfeld, H., Perloff, M. M., Clark, E. L., and Schilling, A., 1975, Triazolam in insomniac family practice patients, Clin. Pharmacol. Ther.18:315–324.
Uhlenhuth, E. H., Rickels, K., Fisher, S., Park, L. C., Lipman, R. S., and Mock, J., 1966, Drug, doctor’s verbal attitude and clinic setting in the symptomatic response to pharmacotherapy, Psychopharmacologia9:392–418.
Uhlenhuth, E. H., Duncan, D. B., and Park, L. C., 1969, Some nonpharmacologic modifiers of the response to Imipramine in depressed psychoneurotic outpatients: A confirmatory study, in: Psychotropic Drug Response: Advances in Prediction (P.R.A. May and J. R. Wittenborn, eds.), pp. 155–197, Charles C. Thomas, Springfield, Illinois.
Uhlenhuth, E. H., Lipman, R. S., Balter, M. B., and Stern, M., 1974, Symptom intensity and life stress in the city, Arch. Gen. Psychiatry31:759–764.
Wheatley, D., 1969a, Comparative effects of propranolol and chlordiazepoxide in anxiety states, Br. J. Psychiatry115:1411–1412.
Wheatley, D., 19696, A comparative trial of imipramine and phenobarbital in depressed patients seen in general practice, J. Nerv. Ment. Dis.148:542–549.
Wheatley, D., 1973, Psychopharmacology in Family Practice, William Heinemann Medical Books, London.
Wickstrom, J., and Haddad, R., 1962, An evaluation of the muscle relaxant properties of chlordiazepoxide: A double-blind study, Am. J. Med. Sci.244:23–29.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1978 Plenum Press, New York
About this chapter
Cite this chapter
Rickels, K., Downing, R.W., Winokur, A. (1978). Antianxiety Drugs: Clinical use in Psychiatry. In: Iversen, L.L., Iversen, S.D., Snyder, S.H. (eds) Handbook of Psychopharmacology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-3189-6_7
Download citation
DOI: https://doi.org/10.1007/978-1-4684-3189-6_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-3191-9
Online ISBN: 978-1-4684-3189-6
eBook Packages: Springer Book Archive